ATEC:NSD-Alphatec Holdings Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 8.03

Change

-0.11 (-1.35)%

Market Cap

USD 0.82B

Volume

0.65M

Avg Analyst Target

USD 16.50 (+105.48%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Alphatec Holdings Inc (ATEC) Stock Analysis:
Based on the Alphatec Holdings Inc stock forecasts from 3 analysts, the average analyst target price for Alphatec Holdings Inc is USD 16.50 over the next 12 months. Alphatec Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Alphatec Holdings Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Alphatec Holdings Inc’s stock price was USD 8.03. Alphatec Holdings Inc’s stock price has changed by -1.47% over the past week, -33.69% over the past month and -45.78% over the last year.

About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperati ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM DexCom Inc

-10.14 (-3.03%)

USD32.85B 171.14 77.12
ALGN Align Technology Inc

-1.32 (-0.48%)

USD21.71B 31.02 18.18
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
PODD Insulet Corporation

-2.15 (-1.08%)

USD13.80B 829.42 84.91
ABMD Abiomed Inc

-0.37 (-0.15%)

USD11.58B 85.29 42.14
BRKR Bruker Corporation

-0.66 (-1.10%)

USD8.99B 33.27 17.75
SWAV ShockWave Medical Inc

+1.24 (+0.76%)

USD5.81B N/A 138.45
IART Integra LifeSciences Holdings ..

+0.39 (+0.66%)

USD4.93B 32.22 16.98
TNDM Tandem Diabetes Care Inc

-1.89 (-2.56%)

USD4.72B 307.71 186.72
IRTC iRhythm Technologies Inc

-6.04 (-4.34%)

USD3.93B N/A N/A

ETFs Containing ATEC

Symbol Name Weight Mer Price(Change) Market Cap
JFWD Jacob Funds Inc. - Jacob .. 0.00 % 0.75 %

-0.51 (-5.25%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.75% 63% D 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.75% 63% D 40% F
Trailing 12 Months  
Capital Gain -45.96% 56% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.96% 56% F 34% F
Trailing 5 Years  
Capital Gain 291.71% 90% A- 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 291.71% 90% A- 93% A
Average Annual (5 Year Horizon)  
Capital Gain 73.88% 83% B 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.88% 83% B 92% A-
Risk Return Profile  
Volatility (Standard Deviation) 111.32% 24% F 12% F
Risk Adjusted Return 66.36% 91% A- 88% B+
Market Capitalization 0.82B 74% C 68% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 19.73 7% F 4% F
Price / Cash Flow Ratio -11.13 79% C+ 78% C+
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -112.53% 18% F 11% F
Return on Invested Capital -36.47% 31% F 25% F
Return on Assets -16.33% 41% F 24% F
Debt to Equity Ratio 159.95% 13% F 13% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 6.42 35% F 23% F
Short Percent 7.17% 21% F 25% F
Beta 1.62 23% F 21% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector